Patents by Inventor Ke-Zhou Zhang

Ke-Zhou Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stanniocalcin polynucleotides, polypeptides and methods based thereon
    Publication number: 20040198658
    Abstract: The present invention relates to human stanniocalcin (STC) polynucleotides, polypeptides, and other Stanniocalcin compositions and to novel methods based thereon. In a specific embodiment, the Stanniocalcin compositions of the invention are used to treat or protect neural cells. Moreover, the present invention relates to vectors, host cells, antibodies, and recombinant and synthetic methods for producing the Stanniocalcin compositions of the invention. Also provided are diagnostic methods for detecting or prognosing diseases, disorders, damage or injury, associated with alterations of the Stanniocalcin compositions of the invention, and to therapeutic methods for treating such diseases, disorders, damage or injury.
    Type: Application
    Filed: July 9, 2003
    Publication date: October 7, 2004
    Applicant: Human Genome Sciences, Inc.
    Inventors: Henrik S. Olsen, Ke-Zhou Zhang, Perttu Lindsberg, Turgut Tatlisumak, Markku Kaste, Leif C. Andersson
  • Stanniocalcin polynucleotides, polypeptides, and methods based thereon
    Publication number: 20020042372
    Abstract: The present invention relates to human stanniocalcin (STC) polynucleotides, polypeptides, and other Stanniocalcin compositions and to novel methods based thereon. In a specific embodiment, the Stanniocalcin compositions of the invention are used to treat or protect neural cells. Moreover, the present invention relates to vectors, host cells, antibodies, and recombinant and synthetic methods for producing the Stanniocalcin compositions of the invention. Also provided are diagnostic methods for detecting or prognosing diseases, disorders, damage or injury, associated with alterations of the Stanniocalcin compositions of the invention, and to therapeutic methods for treating such diseases, disorders, damage or injury.
    Type: Application
    Filed: April 25, 2001
    Publication date: April 11, 2002
    Applicant: Human Genome Sciences, Inc.
    Inventors: Henrik S. Olsen, Ke-Zhou Zhang, Perttu Lindsberg, Turgut Tatlisumak, Markku Kaste, Leif C. Andersson